• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LOX-1-MT1-MMP轴对于内皮细胞中氧化型低密度脂蛋白诱导的RhoA和Rac1激活至关重要。

LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells.

作者信息

Sugimoto Koichi, Ishibashi Toshiyuki, Sawamura Tatsuya, Inoue Nobutaka, Kamioka Masashi, Uekita Hironori, Ohkawara Hiroshi, Sakamoto Takayuki, Sakamoto Nobuo, Okamoto Yasuo, Takuwa Yoh, Kakino Akemi, Fujita Yoshiko, Tanaka Takeshi, Teramoto Tamio, Maruyama Yukio, Takeishi Yasuchika

机构信息

First Department of Internal Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.

出版信息

Cardiovasc Res. 2009 Oct 1;84(1):127-36. doi: 10.1093/cvr/cvp177. Epub 2009 Jun 1.

DOI:10.1093/cvr/cvp177
PMID:19487339
Abstract

AIMS

RhoA and Rac1 activation plays a key role in endothelial dysfunction. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a major receptor for oxidized low-density lipoprotein (ox-LDL) in endothelial cells (ECs). Membrane type 1 matrix metalloproteinase (MT1-MMP) has been shown to be involved in atherogenesis. This study was conducted to investigate the role of the LOX-1-MT1-MMP axis in RhoA and Rac1 activation in response to ox-LDL in ECs.

METHODS AND RESULTS

Ox-LDL induced rapid RhoA and Rac1 activation as well as MT1-MMP activity in cultured human aortic ECs. Inhibition of LOX-1 prevented ox-LDL-dependent RhoA and Rac1 activation. Knockdown of MT1-MMP by small interfering RNA prevented ox-LDL-induced RhoA and Rac1 activation, indicating that MT1-MMP is upstream of RhoA and Rac1. Fluorescent immunostaining revealed the colocalization of LOX-1 and MT1-MMP, and the formation of a complex of LOX-1 with MT1-MMP was detected by immunoprecipitation. Blockade of LOX-1 or MT1-MMP prevented RhoA-dependent endothelial NO synthase protein downregulation and cell invasion, Rac1-mediated NADPH oxidase activity, and reactive oxygen species generation.

CONCLUSION

The present study provides evidence that the LOX-1-MT1-MMP axis plays a crucial role in RhoA and Rac1 activation signalling pathways in ox-LDL stimulation, suggesting that this axis may be a promising target for treating endothelial dysfunction.

摘要

目的

RhoA和Rac1激活在内皮功能障碍中起关键作用。凝集素样氧化低密度脂蛋白受体1(LOX-1)是内皮细胞(ECs)中氧化低密度脂蛋白(ox-LDL)的主要受体。膜型1基质金属蛋白酶(MT1-MMP)已被证明参与动脉粥样硬化的发生。本研究旨在探讨LOX-1-MT1-MMP轴在ECs中对ox-LDL应答时RhoA和Rac1激活中的作用。

方法与结果

ox-LDL在培养的人主动脉ECs中诱导RhoA和Rac1快速激活以及MT1-MMP活性。抑制LOX-1可阻止ox-LDL依赖的RhoA和Rac1激活。小干扰RNA敲低MT1-MMP可阻止ox-LDL诱导的RhoA和Rac1激活,表明MT1-MMP在RhoA和Rac1的上游。荧光免疫染色显示LOX-1和MT1-MMP共定位,免疫沉淀检测到LOX-1与MT1-MMP形成复合物。阻断LOX-1或MT1-MMP可阻止RhoA依赖的内皮型一氧化氮合酶蛋白下调和细胞侵袭、Rac1介导的NADPH氧化酶活性以及活性氧生成。

结论

本研究提供证据表明,LOX-1-MT1-MMP轴在ox-LDL刺激下的RhoA和Rac1激活信号通路中起关键作用,提示该轴可能是治疗内皮功能障碍的一个有前景靶点。

相似文献

1
LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells.LOX-1-MT1-MMP轴对于内皮细胞中氧化型低密度脂蛋白诱导的RhoA和Rac1激活至关重要。
Cardiovasc Res. 2009 Oct 1;84(1):127-36. doi: 10.1093/cvr/cvp177. Epub 2009 Jun 1.
2
Role of LOX-1 in monocyte adhesion-triggered redox, Akt/eNOS and Ca2+ signaling pathways in endothelial cells.凝集素样氧化型低密度脂蛋白受体1(LOX-1)在内皮细胞中单核细胞黏附触发的氧化还原、Akt/内皮型一氧化氮合酶(eNOS)和钙离子(Ca2+)信号通路中的作用
J Cell Physiol. 2009 Sep;220(3):706-15. doi: 10.1002/jcp.21818.
3
Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species.氧化型低密度脂蛋白受体-1介导氧化型低密度脂蛋白诱导人脐静脉内皮细胞凋亡:活性氧的作用
Vascul Pharmacol. 2007 Jul;47(1):1-9. doi: 10.1016/j.vph.2007.01.004. Epub 2007 Jan 30.
4
Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage.凝集素样氧化型低密度脂蛋白受体1介导类风湿关节炎软骨中氧化型低密度脂蛋白增强的基质金属蛋白酶3合成。
Arthritis Rheum. 2004 Nov;50(11):3495-503. doi: 10.1002/art.20581.
5
Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells.阿司匹林可抑制人冠状动脉内皮细胞中氧化型低密度脂蛋白(ox-LDL)介导的凝集素样氧化型低密度脂蛋白受体1(LOX-1)表达及基质金属蛋白酶-1表达。
Cardiovasc Res. 2004 Nov 1;64(2):243-9. doi: 10.1016/j.cardiores.2004.07.002.
6
Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways.膜型基质金属蛋白酶 1(MT1-MMP)在 RAGE 激活信号通路中的作用。
J Cell Physiol. 2011 Jun;226(6):1554-63. doi: 10.1002/jcp.22492.
7
Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose.高糖环境下人内皮细胞中 apocynin 对 NADPH 氧化酶介导的氧化应激-LOX-1-eNOS 通路的影响。
Eur J Pharmacol. 2010 Feb 10;627(1-3):42-8. doi: 10.1016/j.ejphar.2009.10.045. Epub 2009 Oct 28.
8
[Effects of lecithin-like oxidized low-density lipoprotein receptor-1 on p38 mitogen-activated protein kinase induced by oxidized low-density lipoprotein in endothelial cells].[卵磷脂样氧化低密度脂蛋白受体-1对氧化低密度脂蛋白诱导内皮细胞中p38丝裂原活化蛋白激酶的影响]
Zhonghua Yi Xue Za Zhi. 2006 Jun 27;86(24):1697-700.
9
Essential role of NOXA1 in generation of reactive oxygen species induced by oxidized low-density lipoprotein in human vascular endothelial cells.NOXA1在氧化型低密度脂蛋白诱导人血管内皮细胞产生活性氧物种中的重要作用。
Endothelium. 2008 May-Jun;15(3):137-41. doi: 10.1080/10623320802125433.
10
Receptor for advanced glycation end products - membrane type1 matrix metalloproteinase axis regulates tissue factor expression via RhoA and Rac1 activation in high-mobility group box-1 stimulated endothelial cells.晚期糖基化终末产物受体-膜型1基质金属蛋白酶轴通过RhoA和Rac1激活在高迁移率族蛋白B1刺激的内皮细胞中调节组织因子表达。
PLoS One. 2014 Dec 9;9(12):e114429. doi: 10.1371/journal.pone.0114429. eCollection 2014.

引用本文的文献

1
Remdesivir inhibits endothelial activation and atherosclerosis by coupling TAL1 to TRAF6.瑞德西韦通过将TAL1与TRAF6偶联来抑制内皮细胞活化和动脉粥样硬化。
J Transl Med. 2025 Jul 1;23(1):719. doi: 10.1186/s12967-025-06673-2.
2
Molecular Mechanisms of Vascular Tone in Exercising Pediatric Populations: A Comprehensive Overview on Endothelial, Antioxidative, Metabolic and Lipoprotein Signaling Molecules.运动儿童群体中血管张力的分子机制:关于内皮、抗氧化、代谢和脂蛋白信号分子的全面概述
Int J Mol Sci. 2025 Jan 25;26(3):1027. doi: 10.3390/ijms26031027.
3
Oxidative Stress and Inflammation-Related mRNAs Are Elevated in Serum of a Finnish Wet AMD Cohort.
氧化应激和炎症相关的 mRNA 在芬兰湿性 AMD 队列的血清中升高。
Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):30. doi: 10.1167/iovs.65.13.30.
4
The Dectin-1 and Dectin-2 clusters: C-type lectin receptors with fundamental roles in immunity.Dectin-1和Dectin-2簇:在免疫中起基本作用的C型凝集素受体。
EMBO Rep. 2024 Dec;25(12):5239-5264. doi: 10.1038/s44319-024-00296-2. Epub 2024 Oct 31.
5
Decreased Tiam1-mediated Rac1 activation is responsible for impaired directional persistence of chondrocyte migration in microtia.Tiam1 介导的 Rac1 活化减少导致小耳畸形中软骨细胞迁移的定向持续性受损。
J Cell Mol Med. 2024 Jun;28(11):e18443. doi: 10.1111/jcmm.18443.
6
LOX-1 in Cardiovascular Disease: A Comprehensive Molecular and Clinical Review.LOX-1 在心血管疾病中的作用:全面的分子与临床综述。
Int J Mol Sci. 2024 May 12;25(10):5276. doi: 10.3390/ijms25105276.
7
Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process.活性氧、氧化型低密度脂蛋白和凝集素样氧化型低密度脂蛋白受体1:动脉粥样硬化进程中的恶性循环。
Antioxidants (Basel). 2024 May 9;13(5):583. doi: 10.3390/antiox13050583.
8
Is the endotoxin-complement cascade the major driver in lipedema?脂膜炎的主要驱动因素是内毒素-补体级联反应吗?
Trends Endocrinol Metab. 2024 Sep;35(9):769-780. doi: 10.1016/j.tem.2024.04.004. Epub 2024 Apr 29.
9
Klotho inhibits renal ox-LDL deposition via IGF-1R/RAC1/OLR1 signaling to ameliorate podocyte injury in diabetic kidney disease.Klotho 通过 IGF-1R/RAC1/OLR1 信号抑制肾脏 ox-LDL 沉积,改善糖尿病肾病中的足细胞损伤。
Cardiovasc Diabetol. 2023 Oct 27;22(1):293. doi: 10.1186/s12933-023-02025-w.
10
Studies on the Effects of Hypercholesterolemia on Mouse Ophthalmic Artery Reactivity.高胆固醇血症对小鼠眼动脉反应性影响的研究。
Diseases. 2023 Sep 22;11(4):124. doi: 10.3390/diseases11040124.